Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales
出版年份 2013 全文链接
标题
Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 170, Issue 4, Pages 712-729
出版商
Wiley
发表日期
2013-08-21
DOI
10.1111/bph.12344
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vandetanib: A novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer
- (2013) G. N. Ton et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1
- (2013) L. Qin et al. BLOOD
- Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
- (2013) Evangelos Briasoulis et al. BMC CANCER
- Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling
- (2013) Corentin Herbert et al. CANCER CELL
- Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties
- (2013) Françoise Bono et al. CANCER CELL
- Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma
- (2013) E. Angevin et al. CLINICAL CANCER RESEARCH
- v Integrins in Angiogenesis and Cancer
- (2013) S. M. Weis et al. Cold Spring Harbor Perspectives in Medicine
- Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer
- (2012) B. Besse et al. ANNALS OF ONCOLOGY
- Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
- (2012) A. Argiris et al. ANNALS OF ONCOLOGY
- Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy
- (2012) Alessandra Fabi et al. BMC CANCER
- Angiopoietins in angiogenesis
- (2012) Ernesta Fagiani et al. CANCER LETTERS
- AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
- (2012) P. R. Gavine et al. CANCER RESEARCH
- A preclinical and clinical review of aflibercept for the management of cancer
- (2012) Andrew Gaya et al. CANCER TREATMENT REVIEWS
- Discovery and development of N-cadherin antagonists
- (2012) Orest W. Blaschuk CELL AND TISSUE RESEARCH
- Phase I and Clinical Pharmacology Study of Bevacizumab, Sorafenib, and Low-Dose Cyclophosphamide in Children and Young Adults with Refractory/Recurrent Solid Tumors
- (2012) F. Navid et al. CLINICAL CANCER RESEARCH
- Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer
- (2012) Christian Manegold et al. INVESTIGATIONAL NEW DRUGS
- Hypoxia-inducible Factor-1 (HIF-1)-independent Hypoxia Response of the Small Heat Shock Proteinhsp-16.1Gene Regulated by Chromatin-remodeling Factors in the NematodeCaenorhabditis elegans
- (2012) Jihyun Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bevacizumab Advanced Melanoma (BEAM) Was a Positive Trial
- (2012) David R. Minor JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib Versus Placebo in Patients With Advanced Non–Small-Cell Lung Cancer After Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor: A Randomized, Double-Blind Phase III Trial (ZEPHYR)
- (2012) Jin Soo Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
- (2012) Chiun Hsu et al. JOURNAL OF HEPATOLOGY
- Targeting Carcinoma-Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation Protein-Activated Prodrug
- (2012) W. N. Brennen et al. JNCI-Journal of the National Cancer Institute
- Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis
- (2012) Zhi-Yuan Chen et al. Journal of Translational Medicine
- Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
- (2012) Sophie Leboulleux et al. LANCET ONCOLOGY
- The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts
- (2012) E. Bello et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models
- (2012) J. M. Gozgit et al. MOLECULAR CANCER THERAPEUTICS
- A phase I/II trial of vandetanib for patients with recurrent malignant glioma
- (2012) T. N. Kreisl et al. NEURO-ONCOLOGY
- Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer
- (2012) Jeffrey A. Meyerhardt et al. PLoS One
- Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension
- (2012) Cornelia Schuster et al. PLoS One
- Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials
- (2012) Ping Fang et al. PLoS One
- Side effects of anti-angiogenic drugs
- (2012) Francesca Elice et al. THROMBOSIS RESEARCH
- Metastatic Pancreatic Cancer: Are We Making Progress in Treatment?
- (2012) Joanne Chiu et al. Gastroenterology Research and Practice
- Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect
- (2011) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
- (2011) K Dredge et al. BRITISH JOURNAL OF CANCER
- Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part
- (2011) J B Vermorken et al. BRITISH JOURNAL OF CANCER
- Intussusceptive microvascular growth in tumors
- (2011) Domenico Ribatti et al. CANCER LETTERS
- Antiangiogenesis Enhances Intratumoral Drug Retention
- (2011) J. Ma et al. CANCER RESEARCH
- Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer – Review of the literature
- (2011) T. Nelius et al. CANCER TREATMENT REVIEWS
- Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
- (2011) Elizabeth Allen et al. CLINICAL CANCER RESEARCH
- Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?
- (2011) Nicolas Penel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Lipid Mediators in Life Science
- (2011) Makoto MURAKAMI EXPERIMENTAL ANIMALS
- FGF-dependent regulation of VEGF receptor 2 expression in mice
- (2011) Masahiro Murakami et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
- (2011) Hideaki Ijichi et al. JOURNAL OF CLINICAL INVESTIGATION
- Bevacizumab for Advanced Breast Cancer: All Tied Up With a RIBBON?
- (2011) Harold J. Burstein JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
- (2011) Athanassios Argiris et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer
- (2011) Jonathan A. Ledermann et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour macrophages as potential targets of bisphosphonates
- (2011) Thea L Rogers et al. Journal of Translational Medicine
- (-)-Gossypol Suppresses the Growth of Human Prostate Cancer Xenografts via Modulating VEGF Signaling-Mediated Angiogenesis
- (2011) X. Pang et al. MOLECULAR CANCER THERAPEUTICS
- Potent Inhibition of Angiogenesis by the IGF-1 Receptor-Targeting Antibody SCH717454 Is Reversed by IGF-2
- (2011) H. K. Bid et al. MOLECULAR CANCER THERAPEUTICS
- Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer
- (2011) J. Taeger et al. MOLECULAR CANCER THERAPEUTICS
- A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models
- (2011) G. Zhao et al. MOLECULAR CANCER THERAPEUTICS
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis
- (2011) He Zhou et al. PLoS One
- Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
- (2011) Amit Dutt et al. PLoS One
- Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2
- (2011) S. MacLauchlan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?
- (2011) Alberto J. Montero et al. Current Oncology Reports
- Tumor Angiogenesis as a Target for Dietary Cancer Prevention
- (2011) William W. Li et al. Journal of Oncology
- Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
- (2010) J D Veltman et al. BRITISH JOURNAL OF CANCER
- Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration
- (2010) Roger A. Sabbadini BRITISH JOURNAL OF PHARMACOLOGY
- Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis
- (2010) X. Cui et al. Cancer Prevention Research
- Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
- (2010) E. Giannoni et al. CANCER RESEARCH
- Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Maintenance therapy in colon cancer
- (2010) F. Giuliani et al. CANCER TREATMENT REVIEWS
- PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
- (2010) C. C. Zhang et al. CLINICAL CANCER RESEARCH
- Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts
- (2010) W.-m. Zhao et al. CLINICAL CANCER RESEARCH
- Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence: Table 1
- (2010) Lauren M. Willis et al. CLINICAL SCIENCE
- Targeting of drugs and nanoparticles to tumors
- (2010) Erkki Ruoslahti et al. JOURNAL OF CELL BIOLOGY
- Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer
- (2010) Eric B. Haura et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth
- (2010) Ken D. Johnstone et al. JOURNAL OF MEDICINAL CHEMISTRY
- METRONOMIC CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH ADVANCED, CASTRATION-RESISTANT PROSTATE CANCER
- (2010) Andrea Fontana et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer
- (2010) Fiona H. Blackhall et al. Journal of Thoracic Oncology
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- The Farnesyltransferase Inhibitor LB42708 Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Inhibiting Ras-dependent Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signal Pathways
- (2010) C.-K. Kim et al. MOLECULAR PHARMACOLOGY
- Nanoparticulate Delivery System Targeted to Tumor Neovasculature for Combined Anticancer and Antiangiogenesis Therapy
- (2010) Zhe Wang et al. PHARMACEUTICAL RESEARCH
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
- (2010) Dimitra Bourboulia et al. SEMINARS IN CANCER BIOLOGY
- Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact
- (2010) F. Elice et al. THROMBOSIS RESEARCH
- Management of hypertension in angiogenesis inhibitor-treated patients
- (2009) H. Izzedine et al. ANNALS OF ONCOLOGY
- Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor
- (2009) Jerry Y. Hsu et al. BIODRUGS
- Chemokines in tumor-associated angiogenesis
- (2009) Peter Arne Gerber et al. BIOLOGICAL CHEMISTRY
- Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
- (2009) D Yoshikawa et al. BRITISH JOURNAL OF CANCER
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
- (2009) Laetitia Devy et al. CANCER RESEARCH
- Dominant Effect of Antiangiogenesis in Combination Therapy Involving Cyclophosphamide and Axitinib
- (2009) J. Ma et al. CLINICAL CANCER RESEARCH
- Antivascular Actions of Microtubule-Binding Drugs
- (2009) E. L. Schwartz CLINICAL CANCER RESEARCH
- Proteasome Inhibitor MG132 Inhibits Angiogenesis in Pancreatic Cancer by Blocking NF-κB Activity
- (2009) Yoichi Matsuo et al. DIGESTIVE DISEASES AND SCIENCES
- Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
- (2009) Marta Coscia et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
- (2009) Yoshiaki Kubota et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
- (2009) Chun-Jen Liu et al. JOURNAL OF HEPATOLOGY
- Endogenous inhibitors of angiogenesis
- (2009) Domenico Ribatti LEUKEMIA RESEARCH
- Targeting of Tumor Blood Vessels: A Phage-Displayed Tumor-Homing Peptide Specifically Binds to Matrix Metalloproteinase-2-Processed Collagen IV and Blocks Angiogenesis In vivo
- (2009) J. Mueller et al. MOLECULAR CANCER RESEARCH
- JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia
- (2009) C. L. Manthey et al. MOLECULAR CANCER THERAPEUTICS
- An overview of small-molecule inhibitors of VEGFR signaling
- (2009) S. Percy Ivy et al. Nature Reviews Clinical Oncology
- Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
- (2009) H. Jarvelainen et al. PHARMACOLOGICAL REVIEWS
- Diabetic Retinopathy: Current Management and Experimental Therapeutic Targets
- (2009) Tayyeba K Ali et al. PHARMACOTHERAPY
- PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to Anti-VEGF Treatment
- (2009) Emmanuelle di Tomaso et al. PLoS One
- The angiogenic switch in carcinogenesis
- (2009) Vanessa Baeriswyl et al. SEMINARS IN CANCER BIOLOGY
- Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion
- (2008) Georgios T. Stathopoulos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- (2008) S. A. Eccles et al. CANCER RESEARCH
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Antiangiogenic Therapy with Mammalian Target of Rapamycin Inhibitor RAD001 (Everolimus) Increases Radiosensitivity in Solid Cancer
- (2008) P. C. Manegold et al. CLINICAL CANCER RESEARCH
- The tumor microenvironment and its contribution to tumor evolution toward metastasis
- (2008) Girieca Lorusso et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Retracted: TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer
- (2008) Zhiwei Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
- (2008) J. Ma et al. MOLECULAR CANCER THERAPEUTICS
- HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
- (2008) Zoltan Arany et al. NATURE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts
- (2008) S Shahrzad et al. ONCOGENE
- CXCR2 antagonists for the treatment of pulmonary disease
- (2008) R.W. Chapman et al. PHARMACOLOGY & THERAPEUTICS
- Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
- (2008) E. A. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity
- (2008) H. P. Eikesdal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression
- (2008) F. Shojaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
- (2007) V. W.M. van Hinsbergh et al. CARDIOVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now